CAS 1477497-01-0

6-(4-((3-(Benzyloxy)benzyl)oxy)-6-methoxybenzofuran-2-yl)-2-methoxyimidazo[2,1-b][1,3,4]thiadiazole

CAS : 1477497-01-0

6-(4-((3-(Benzyloxy)benzyl)oxy)-6-methoxybenzofuran-2-yl)-2-methoxyimidazo[2,1-b][1,3,4]thiadiazole (6BZT) is a high purity chemical reagent that is used in the field of Life Sciences for research purposes and as a pharmacological tool. 6BZT has been shown to activate the G protein coupled receptor (GPCR). 6BZT binds to the agonist binding site on the GPCR and activates it by increasing intracellular cAMP levels. The activation of this receptor can be observed in cell biology experiments using immunofluorescent staining or western blotting. Research using 6BZT has shown that it inhibits both potassium and sodium ion channels, which are important for cellular function. It also inhibits peptide ligand interactions with its receptor. 6BZ

Formule : C₂₈H₂₃N₃O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 513.6 g/mol

Ref: 3D-CJC49701

UDM-001651

CAS : 1477497-01-0

UDM-001651: oral PAR4 antagonist, IC50=4 nM, Kd=1.4 nM, antiplatelet IC50=25 nM in γ-thrombin assay.

Formule : C₂₈H₂₃N₃O₅S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 513.56

Ref: TM-T17200